Health is fluid.

ImpediMed’s bioimpedance spectroscopy (BIS) devices accurately and noninvasively measure a patient’s total body water, and extracellular and intracellular fluid volumes to aid in the assessment and interventions for chronic diseases.

SOZO®, the world’s most advanced, noninvasive BIS device, gives healthcare professionals a precise snapshot of fluid status and tissue composition in less than 30 seconds*.
*As tested on Android

Now Available!
SOZO Reimagined — NEW Software Version 4.0

Intuitive Redesign, Powerful Data, Enhanced Security

BIS Technology

BIS Technology

BIS is the only noninvasive, low-cost technology that can accurately measure fluid status and tissue composition in a clinical setting.

Impedimed product

L-Dex® Score

For patients at risk of lymphedema, establishing a baseline L-Dex score and taking regular measurements can help clinicians prevent disease progression.

Impedimedi-did you know image

Clinical Evidence

ImpediMed’s BIS devices have been studied extensively and clinically validated in over 40 medical conditions.

SOZO Featuring L-Dex Assessment

SOZO in Clinical Practice

SOZO, the world’s most advanced, noninvasive bioimpedance spectroscopy (BIS) device, incorporates L-Dex technology to aid in the assessment of secondary lymphedema and to deliver a precise snapshot of fluid status and tissue composition in less than 30 seconds*. A single, powerful SOZO reading allows clinicians across multiple specialties to provide individualized, proactive care that can help improve patient outcomes.

*As tested on Android

See the power of SOZO
Healthcare Professional

Specialty

Understanding dynamic changes in patient fluid and tissue status can help you provide more timely interventions.

Patients

Patient Resources

Early detection of lymphedema, followed by timely treatment as directed by your doctor, can help you effectively manage your symptoms.

Investors

Investor Relations

Strong demand for our advanced medical devices and digital health platform are fueling ImpediMed’s growth.